BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38762624)

  • 1. Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling.
    Galloni C; Egnuni T; Zahed Mohajerani S; Ye J; Mittnacht S; Speirs V; Lorger M; Mavria G
    Commun Biol; 2024 May; 7(1):602. PubMed ID: 38762624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dock4 forms a complex with SH3YL1 and regulates cancer cell migration.
    Kobayashi M; Harada K; Negishi M; Katoh H
    Cell Signal; 2014 May; 26(5):1082-8. PubMed ID: 24508479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics.
    Xiao Y; Peng Y; Wan J; Tang G; Chen Y; Tang J; Ye WC; Ip NY; Shi L
    J Biol Chem; 2013 Jul; 288(27):20034-45. PubMed ID: 23720743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
    Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASAL2 activates RAC1 to promote triple-negative breast cancer progression.
    Feng M; Bao Y; Li Z; Li J; Gong M; Lam S; Wang J; Marzese DM; Donovan N; Tan EY; Hoon DS; Yu Q
    J Clin Invest; 2014 Dec; 124(12):5291-304. PubMed ID: 25384218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis.
    Yu JR; Tai Y; Jin Y; Hammell MC; Wilkinson JE; Roe JS; Vakoc CR; Van Aelst L
    Genes Dev; 2015 Feb; 29(3):250-61. PubMed ID: 25644601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stretch of polybasic residues mediates Cdc42 GTPase-activating protein (CdGAP) binding to phosphatidylinositol 3,4,5-trisphosphate and regulates its GAP activity.
    Karimzadeh F; Primeau M; Mountassif D; Rouiller I; Lamarche-Vane N
    J Biol Chem; 2012 Jun; 287(23):19610-21. PubMed ID: 22518840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
    Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
    Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
    Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
    Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
    Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
    Ma J; Xue Y; Liu W; Yue C; Bi F; Xu J; Zhang J; Li Y; Zhong C; Chen Y
    PLoS One; 2013; 8(6):e66275. PubMed ID: 23750283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
    Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
    Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracellular and transcellular migration of metastatic cells through the cerebral endothelium.
    Herman H; Fazakas C; Haskó J; Molnár K; Mészáros Á; Nyúl-Tóth Á; Szabó G; Erdélyi F; Ardelean A; Hermenean A; Krizbai IA; Wilhelm I
    J Cell Mol Med; 2019 Apr; 23(4):2619-2631. PubMed ID: 30712288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac signaling in breast cancer: a tale of GEFs and GAPs.
    Wertheimer E; Gutierrez-Uzquiza A; Rosemblit C; Lopez-Haber C; Sosa MS; Kazanietz MG
    Cell Signal; 2012 Feb; 24(2):353-362. PubMed ID: 21893191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
    Westbrook JA; Wood SL; Cairns DA; McMahon K; Gahlaut R; Thygesen H; Shires M; Roberts S; Marshall H; Oliva MR; Dunning MJ; Hanby AM; Selby PJ; Speirs V; Mavria G; Coleman RE; Brown JE
    J Pathol; 2019 Mar; 247(3):381-391. PubMed ID: 30426503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.
    Huang L; Chambliss KL; Gao X; Yuhanna IS; Behling-Kelly E; Bergaya S; Ahmed M; Michaely P; Luby-Phelps K; Darehshouri A; Xu L; Fisher EA; Ge WP; Mineo C; Shaul PW
    Nature; 2019 May; 569(7757):565-569. PubMed ID: 31019307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis.
    Abraham S; Scarcia M; Bagshaw RD; McMahon K; Grant G; Harvey T; Yeo M; Esteves FOG; Thygesen HH; Jones PF; Speirs V; Hanby AM; Selby PJ; Lorger M; Dear TN; Pawson T; Marshall CJ; Mavria G
    Nat Commun; 2015 Jul; 6():7286. PubMed ID: 26129894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
    Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
    Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
    Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.